CRKL promotes proliferation, migration, invasion of laryngeal squamous cell carcinoma.
CONCLUSIONS: These findings suggested that CRKL gene silencing significantly inhibited the proliferation, migration, invasion, and EMT signaling pathway of Hep-2 cells. CRKL is considered to be a new target for the treatment of LSCC.
PMID: 32495882 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Epithelial Cancer | Genetics | Laryngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study